Name of bioresource/bank
Name of Principal Investigator
Address of institution where award is held
|Institution||International Institute of Molecular and Cell Biology (IIMCB)|
|Street Address||Trojdena 4|
Contact email (e.g. manager or coordinator)
Governmental grants PolStu, PolSEnior
Q1 What conditions does your resource cover?
Alzheimer’s disease and other dementias Neurodegenerative disease in general
Q2a What DNA collection does your resources hold?
Q2b What cell lines does your resource hold?
101-500 distinct cell lines
Q2c What tissue (including post-mortem tissue) does your resource hold?
Q3 Are human tissues/samples/DNA from
Living donors:blood Living donors: blood derivatives Living donors: DNA
Q4 Are tissues/samples/DNA from
Healthy individuals/control donors Patients
Q5 Can samples be linked to clinical (phenotypic) information and if so, is this information:
Collected as part of a specific clinical trial(s)
Q6 In what form are samples supplied?
Primary samples: Supplied fresh Primary Samples: Stabilised samples (frozen or fixed) Secondary samples: plasma Secondary samples: DNA Secondary samples: RNA Secondary samples: protein extracts Secondary samples: cell lines derived from primary samples
Q7 Are biomarkers/analytes/biological characteristics already measured and the information available for your samples?
In most samples
Q8 What is the status of your tissue/sample/DNA collection?
Collection closed to access
Q9 What are the rules and procedures for access?
Access through collaboration with PI only